James Young
Chairman en NOVAVAX, INC. .
Fortuna: 346 245 $ al 29/02/2024
Perfil
En la actualidad, James F. Young ocupa el cargo de presidente de Novavax, Inc. y presidente de MedImmune Oncology, Inc. El Dr. Young también forma parte del consejo de Sagimet Biosciences, Inc. y de CannaRoyalty Corp. En su trayectoria profesional anterior, el Dr. Young fue presidente de La Jolla Capital, Inc., presidente, director ejecutivo y financiero de Targeted Microwave Solutions, Inc., presidente de investigación y desarrollo de MedImmune LLC, director del departamento de genética molecular de Smith Kline & French Laboratories Ltd. y miembro del cuerpo docente de la Facultad de Medicina del Icah en el Monte Sinaí. James F. Young se doctoró en el Baylor College of Medicine y se licenció en la Universidad de Villanova.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
NOVAVAX, INC.
0.06% | 12/06/2023 | 70 090 ( 0.06% ) | 346 245 $ | 29/02/2024 |
12/07/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
Cargos activos de James Young
Empresas | Cargo | Inicio |
---|---|---|
NOVAVAX, INC. | Chairman | 20/04/2011 |
ORIGIN HOUSE | Director/Board Member | - |
MedImmune Oncology, Inc.
MedImmune Oncology, Inc. BiotechnologyHealth Technology MedImmune Oncology, Inc. engages in the clinical development of medicines to treat cancer. The company is headquartered in Gaithersburg, MD. | President | - |
Antiguos cargos conocidos de James Young.
Empresas | Cargo | Fin |
---|---|---|
SAGIMET BIOSCIENCES INC. | Director/Board Member | 13/07/2023 |
TARGETED MICROWAVE SOLUTIONS INC. | Chief Executive Officer | 01/11/2018 |
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California. | Director/Board Member | 10/07/2013 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | - |
XENCOR, INC. | Director/Board Member | 01/01/2008 |
Formación de James Young.
Villanova University | Undergraduate Degree |
Baylor College of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 5 |
---|---|
NOVAVAX, INC. | Health Technology |
XENCOR, INC. | Health Technology |
ORTHOGONAL GLOBAL GROUP INC. | Finance |
SAGIMET BIOSCIENCES INC. | Health Technology |
TARGETED MICROWAVE SOLUTIONS INC. | Producer Manufacturing |
Empresas privadas | 7 |
---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California. | Health Technology |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
Smith Kline & French Laboratories Ltd.
Smith Kline & French Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Smith Kline & French Laboratories Ltd. manufactures pharmaceutical products. The company is headquartered in Brentford, the United Kingdom. | Health Technology |
CannaRoyalty Corp.
CannaRoyalty Corp. Agricultural Commodities/MillingProcess Industries CannaRoyalty Corp. engages in the field of legal cannabis. The company was founded in February, 2015, and is headquartered in Ottawa, Canada. | Process Industries |
MedImmune Oncology, Inc.
MedImmune Oncology, Inc. BiotechnologyHealth Technology MedImmune Oncology, Inc. engages in the clinical development of medicines to treat cancer. The company is headquartered in Gaithersburg, MD. | Health Technology |
The Phillips Collection
The Phillips Collection Other Consumer ServicesConsumer Services The Phillips Collection operates as an art museum that provides a collection of French impressionism and American modernism to contemporary art. The museum's collection includes works by American and European masters such as Paul Cézanne, Edgar Degas, Winslow Homer, Henri Matisse, Georgia O'Keeffe, Pablo Picasso, Mark Rothko, and Vincent van Gogh. The company was founded by Duncan Phillips and is headquartered in Washington, DC. | Consumer Services |